Effect of N-Acetylcysteine on Residual Renal Function in Chronic Hemodialysis Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2007 by Assaf-Harofeh Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Assaf-Harofeh Medical Center
ClinicalTrials.gov Identifier:
NCT00507052
First received: July 24, 2007
Last updated: NA
Last verified: July 2007
History: No changes posted
  Purpose

In our opinion, it is worth to check an ability of antioxidant therapy to produce a favorable effect on Residual Renal Function.

The aim of our study is to investigate the effect of N-acetylsysteine on RRF in prevalent HD patients.


Condition Intervention
Hemodialysis
Renal Failure
Drug: N-acetylcysteine

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label

Resource links provided by NLM:


Further study details as provided by Assaf-Harofeh Medical Center:

  Eligibility

Ages Eligible for Study:   20 Years to 90 Years
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Patients with ESRD, treated with chronic hemodialysis

Exclusion Criteria:

  • Patients will be excluded from the study if they are:

    1. Patients with acute renal failure
    2. Currently treated with antioxidants ( NAC, vitamin E ets.)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00507052

Contacts
Contact: Leonid S Feldman, MD +972-8-9779383 ext +972 leonidf@asaf.health.gov.il

Locations
Israel
Assaf Harofeh Not yet recruiting
Zerifin, Israel, 70300
Contact: Leonid S Feldman, MD    +972-8-9779383 ext +972    leonidf@asaf.health.gov.il   
Sponsors and Collaborators
Assaf-Harofeh Medical Center
Investigators
Principal Investigator: Leonid S Feldman, MD Assaf Harofeh MC
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00507052     History of Changes
Other Study ID Numbers: 346147RRF
Study First Received: July 24, 2007
Last Updated: July 24, 2007
Health Authority: Israel: Ministry of Health

Keywords provided by Assaf-Harofeh Medical Center:
Hemodialysis
Residual Renal Function

Additional relevant MeSH terms:
Renal Insufficiency
Kidney Diseases
Urologic Diseases
Acetylcysteine
N-monoacetylcystine
Antiviral Agents
Anti-Infective Agents
Therapeutic Uses
Pharmacologic Actions
Expectorants
Respiratory System Agents
Free Radical Scavengers
Antioxidants
Molecular Mechanisms of Pharmacological Action
Protective Agents
Physiological Effects of Drugs
Antidotes

ClinicalTrials.gov processed this record on August 28, 2014